-
-
-
Voice of China at ESSO | FUSCC was invited to the international stage, showcasing the wisdom and elegance of Chinese colorectal oncologists
From October 2nd to 4th, 2024, the 43rd Congress of the European Society of Surgical Oncology (ESSO) was held in Antwerp, Belgium.
-
-
Chinese prostate cancer drug shows promising results
A multi-center research project consisting of 72 top urinary cancer centers in China and abroad confirmed that a Chinese-developed prostate cancer drug can reduce mortality rates by 42 percent and reduce the risk of other cancerous developments by 56 perc
-
-
The researches from Fudan University Shanghai Cancer Center mapped the proteogenomic profile of clear cell renal cell carcinoma
China is a country with the large number of kidney cancer, and about 40% of patients are diagnosed with metastatic renal cancer or occure distant metastasis during disease follow-up, which leads to poor treatment outcomes. High genetic heterogeneity and
-
-
A novel method to reconstruct recurrent laryngeal nerve
reported by Department of Head &Neck Surgery, Fudan University Shanghai Cancer Center “Head & Neck”, the official journal of International Federation of Head and Neck Oncologic Societies (IFHNOS) and International Academy of Oral
-
-
The researches from Fudan University Shanghai Cancer Center find the regulatory mechanism for the progression of the Triple-negative breast cancer
Triple-negative breast cancer (TNBC), which accounts for approximately 15%-20% of all breast cancer cases, is characterized by high malignancy and a lack of effective targeted therapy. Patients with TNBC have an increased risk of distant recurrence
-
NEWS
-
- -A new breakthrough of immunotherapy for luminal-type breast cancer
- -Voice of China at ESSO | FUSCC was invited to the international stage, showcasing the wisdom and elegance of Chinese colorectal oncologists
- -Non-invasive test developed for urological cancer
- -Doctor's pioneering research can light up hidden cancers
